CREUTZFELD-JAKOB DISEASE - RECOMMENDATIONS FOR INFECTION-CONTROL

被引:42
作者
STEELMAN, VM
机构
[1] University of Iowa Hospitals and Clinics, Iowa City, IA
关键词
D O I
10.1016/0196-6553(94)90019-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Creutzfeld-Jakob disease, an infectious, progressive, degenerative neurologic disorder, has a presumably long incubation period but a rapid, fatal course. Brain tissue at autopsy resembles that seen in spongioform encephalopathies of other species. Creutzfeld-Jakob disease is transmitted by a proteinaceous infectious agent, or ''prion.'' Epidemiologic patterns remain uncertain; various studies have reported conflicting risk factors in different populations, and genetic susceptibility may be involved. Although natural transmission routes are still unclear, both iatrogenic and nosocomial transmissions have been identified. Transmission has occurred through contaminated electrodes, contaminated biologic products from cadaveric brains, and infected donor tissues, including dura mater and corneas. Because the prion is difficult to eradicate, stringent sterilization precautions must be taken with all surgical instruments. Some tissues and body fluids (e.g., brain, ocular, central nervous system) from the patient with Creutzfeld-Jakob disease are highly infectious and must be contained or incinerated. Some body fluids, however, are not considered infectious. Persons with known or suspected Creutzfeld-Jakob disease, or with exposure to potential sources of iatrogenic infection, should not be considered as donors for any tissues or biologic products. Occupational transmission to health care and pathology workers is also possible. Therefore, specific preventive measures are necessary. Many questions remain regarding transmission and risk factors for Creutzfeld-Jakob syndrome, and the precautions presented here must be considered only preliminary.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 47 条
  • [1] Bendheim, The human spongiform encephalopathies, Neurol Clin, 2, pp. 281-298, (1984)
  • [2] Davanipour, Alter, Sobel, Creutzfeldt-Jakob disease, Neurol Clin, 4, pp. 415-426, (1986)
  • [3] Gibbs, Gajdusek, Asher, Beck, Daniel, Matthews, Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee, Science, 161, pp. 388-389, (1968)
  • [4] Carp, Kascsak, Wisniewski, Et al., The nature of the unconventional slow infection agents remains a puzzle, Alzheimer Dis Assoc Disord, 3, pp. 79-99, (1989)
  • [5] Prusiner, McKinley, Bowman, Et al., Scrapie priors aggregate to form amyloid-like birefringent rods, Cell, 35, pp. 349-358, (1983)
  • [6] Merz, Somerville, Wisniewski, Manuelidis, Manuelidis, Scrapie-associated fibrils in CreutzfeldtJakob disease, Nature, 306, pp. 474-476, (1983)
  • [7] Brown, Cathala, Raubertas, Gajdusek, Castaigne, The epidemiology of Creutzfeldt-Jakob disease: conclusion of a 15-year investigation in France and review of the world literature, Neurology, 37, pp. 895-904, (1987)
  • [8] Kahana, Alter, Braham, Sofer, Creutzfeldt-Jakob disease: focus among Libyan Jews in Israel, Science, 183, pp. 90-91, (1973)
  • [9] Harries-Jones, Knight, Will, Cousens, Smith, Matthews, Creutzfeldt-Jakob disease in England and Wales, 1980–1984: a case-control study of potential risk factors, J Neurol Neurosurg Psychiatry, 51, pp. 1113-1139, (1988)
  • [10] Davanipour, Alter, Sobel, Asher, Gajdusek, Transmissible virus dementia: evaluation of a zoonotic hypothesis, Neuroepidemiology, 5, pp. 194-206, (1985)